Ep. 172 - AACR Insights

from BioCentury This Week · host BioCentury

BioCentury’s analysis of AACR 2023 abstracts found new targets light on immuno-oncology, said Executive Director Lauren Martz on a special edition of the BioCentury This Week podcast. Martz and colleagues debated whether the findings suggest immuno-oncology is losing its luster, and assessed abstracts on next-generation PRMT5 inhibitors and first-in-human studies, as well as the latest data from Merck & Co. and Moderna on their neoantigen vaccine in melanoma.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Apr 20, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 172 - AACR Insights

0:00 22:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 22 minutes long.

When was this BioCentury This Week episode published?

This episode was published on April 20, 2023.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!